These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 10532605)

  • 21. Prevention of transmission of human T-lymphotropic virus type 1 (HTLV-1) through transfusion, by donor screening with antibody to the virus. One-year experience.
    Inaba S; Sato H; Okochi K; Fukada K; Takakura F; Tokunaga K; Kiyokawa H; Maeda Y
    Transfusion; 1989 Jan; 29(1):7-11. PubMed ID: 2643213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transmission of retroviruses from seronegative donors by transfusion during cardiac surgery. A multicenter study of HIV-1 and HTLV-I/II infections.
    Nelson KE; Donahue JG; Muñoz A; Cohen ND; Ness PM; Teague A; Stambolis VA; Yawn DH; Callicott B; McAllister H
    Ann Intern Med; 1992 Oct; 117(7):554-9. PubMed ID: 1524329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimation of the window period of human T-cell leukemia virus type 1 and 2 tests by a lookback study of seroconverters among Japanese voluntary blood donors.
    Sagara Y; Nakamura H; Yamamoto M; Ezaki T; Koga T; Shimamura M; Satake M; Irita K
    Transfusion; 2021 Feb; 61(2):484-493. PubMed ID: 33368334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
    Blejer JL; Saguier MC; Salamone HJ; Carreras LA
    Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion.
    Manns A; Wilks RJ; Murphy EL; Haynes G; Figueroa JP; Barnett M; Hanchard B; Blattner WA
    Int J Cancer; 1992 Jul; 51(6):886-91. PubMed ID: 1639536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of donor screening for HTLV-I and the natural history of transfusion-transmitted infection.
    Inaba S; Okochi K; Sato H; Fukada K; Kinukawa N; Nakata H; Kinjyo K; Fujii F; Maeda Y
    Transfusion; 1999 Oct; 39(10):1104-10. PubMed ID: 10532605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human T-cell lymphotropic virus type I and II in transfusion medicine.
    Sandler SG; Fang CT; Williams AE
    Transfus Med Rev; 1991 Apr; 5(2):93-107. PubMed ID: 1687974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human T-lymphotropic virus type I infection.
    Manns A; Hisada M; La Grenade L
    Lancet; 1999 Jun; 353(9168):1951-8. PubMed ID: 10371587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infection with human T-lymphotropic virus types-1 and -2 (HTLV-1 and -2): Implications for blood transfusion safety.
    Murphy EL
    Transfus Clin Biol; 2016 Feb; 23(1):13-9. PubMed ID: 26778839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adult T-cell leukemia.
    Takatsuki K
    Intern Med; 1995 Oct; 34(10):947-52. PubMed ID: 8563094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Human T-lymphotrophic virus type I and II--diagnosis and clinical presentation].
    Christiansen CB
    Ugeskr Laeger; 1994 Dec; 156(51):7663-7. PubMed ID: 7839528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human T-lymphotropic virus type I (HTLV-I) and tropical spastic paraparesis or HTLV-I-associated myelopathy in Hawaii.
    Dixon PS; Bodner AJ; Okihiro M; Milbourne A; Diwan A; Nakamura JM
    West J Med; 1990 Mar; 152(3):261-7. PubMed ID: 2139754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of transfusion-transmitted human T-cell lymphotropic virus-type I in Latin America.
    Gotuzzo E
    Int J Infect Dis; 2000; 4(2):59-61. PubMed ID: 10737839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HTLV testing in blood transfusion.
    Couroucé AM; Pillonel J; Lemaire JM; Saura C
    Vox Sang; 1998; 74 Suppl 2():165-9. PubMed ID: 9704441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transfusion transmitted human T-lymphotropic virus infections.
    Grillner L
    Acta Anaesthesiol Scand Suppl; 1988; 89():16-9. PubMed ID: 3067484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An update on transfusion-transmitted viruses.
    Luban NL
    Curr Opin Pediatr; 1998 Feb; 10(1):53-9. PubMed ID: 9529639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HTLV-I-associated infective dermatitis: past, present, and future.
    La Grenade L
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S46-9. PubMed ID: 8797703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transfusion transmission of human T-lymphotropic virus types I and II: lessons to be learned from look-back investigations and implications for patient counseling.
    Levine PH; Manns A
    Transfusion; 1993 Jan; 33(1):4-6. PubMed ID: 8379967
    [No Abstract]   [Full Text] [Related]  

  • 40. Donor-transmitted HTLV-1-associated myelopathy in a kidney transplant recipient--case report and literature review.
    Ramanan P; Deziel PJ; Norby SM; Yao JD; Garza I; Razonable RR
    Am J Transplant; 2014 Oct; 14(10):2417-21. PubMed ID: 25138148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.